4-Aminosalicylic acid

Active ingredient description

Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis. It inhibits the onset of bacterial resistance to streptomycin and isoniazid.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
J04AA01
Aminosalicylic acid
J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AA Aminosalicylic acid and derivatives
Discover more medicines within J04AA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
GRANUPAS Gastro-resistant granules
Summary of Product Characteristics (SPC)

Medicines

4-Aminosalicylic acid is the active ingredient of these drugs:

Drug
Countries
GRANUPAS

Austria Estonia Finland France Ireland

PASER

South Africa United States

QUADRASA

France

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 153.135 g/mol

External identifiers

CAS Substance: 65-49-6
DrugBank Drug: DB00233
KEGG Drug: D00162
PubChem Compound: 4649
RxNorm Ingredient: 7833
SNOMED-CT Concept: 27192005
Aminosalicylic acid (substance)
UNII Identifier: 5B2658E0N2
AMINOSALICYLIC ACID
 
Next: Usage >